These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 25173767)

  • 21. Investigation of the safety of irreversible electroporation in humans.
    Thomson KR; Cheung W; Ellis SJ; Federman D; Kavnoudias H; Loader-Oliver D; Roberts S; Evans P; Ball C; Haydon A
    J Vasc Interv Radiol; 2011 May; 22(5):611-21. PubMed ID: 21439847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma.
    Yan L; Chen YL; Su M; Liu T; Xu K; Liang F; Gu WQ; Lu SC
    Chin Med J (Engl); 2016 Dec; 129(24):2920-2925. PubMed ID: 27958223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible electroporation for the ablation of pancreatic malignancies: A patient-specific methodology.
    Latouche EL; Sano MB; Lorenzo MF; Davalos RV; Martin RCG
    J Surg Oncol; 2017 May; 115(6):711-717. PubMed ID: 28185295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
    Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
    Martin RC; McFarland K; Ellis S; Velanovich V
    J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-frequency irreversible electroporation for cardiac ablation using an asymmetrical waveform.
    van Es R; Konings MK; Du Pré BC; Neven K; van Wessel H; van Driel VJHM; Westra AH; Doevendans PAF; Wittkampf FHM
    Biomed Eng Online; 2019 Jun; 18(1):75. PubMed ID: 31221146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
    Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
    Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous irreversible electroporation of a renal tumor: Anesthetic management.
    de la Flor-Robledo M; Solís-Muñoz P; Sanjuán-Álvarez M; Abadal-Villayandre JM; Asensio-Merino F
    Rev Esp Anestesiol Reanim; 2016; 63(7):419-22. PubMed ID: 26874983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible Electroporation of Hepatic and Pancreatic Malignancies: Radiologic-Pathologic Correlation.
    Gonzalez-Beicos A; Venkat S; Songrug T; Poveda J; Garcia-Buitrago M; Poozhikunnath Mohan P; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):176-82. PubMed ID: 26365548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
    Dunki-Jacobs EM; Philips P; Martin RC
    Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Irreversible electroporation: a new form of image-guided tumour ablation].
    Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
    Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reply from the authors. Anaesthetic management during open and percutaneous irreversible electroporation.
    Nielsen K; Scheffer HJ; Vieveen JM; van den Tol P; Meijerink MR; Bouwman RA
    Br J Anaesth; 2015 Sep; 115(3):473-4. PubMed ID: 26269471
    [No Abstract]   [Full Text] [Related]  

  • 35. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.
    Schoellhammer HF; Goldner B; Merchant SJ; Kessler J; Fong Y; Gagandeep S
    BMC Cancer; 2015 Apr; 15():271. PubMed ID: 25886376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
    Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
    Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
    Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
    J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.
    Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I
    Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.